Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely naftidrofuryl oxalate 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely nortriptyline hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely oxazepam 15 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely tolmetin sodium 400 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely phenytoin sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 160 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Furosemide 20 mg and spironolactone 50 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Tramadol hydrochloride 50 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely temozolomide 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Tetracycline 100 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Mexiletine hydrochloride 50 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely clodronate disodium 400 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Prazosin hydrochloride 1 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely nicardipine hydrochloride 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely tiotixene hydrochloride 1 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely mexiletine hydrochloride 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
fluoxetinhydroklorid 50 milligram och olanzapin 6 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Nicardipine hydrochloride 30 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Ursodeoxycholic acid 300 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely tiotixene hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Temozolomide 20 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely zonisamide 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
Product containing precisely trientine hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely trientine hydrochloride 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
cefalexin (som cefalexinmonohydrat) 500 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
cefalexin (som cefalexinmonohydrat) 500 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
cefalexin (som cefalexinmonohydrat) 250 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
cefalexin (som cefalexinmonohydrat) 250 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely sibutramine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely sibutramine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Sibutramine hydrochloride 15 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Sibutramine hydrochloride 15 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Tetracycline (as tetracycline hydrochloride) 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Tetracycline (as tetracycline hydrochloride) 250 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Acebutolol (as acebutolol hydrochloride) 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Acebutolol (as acebutolol hydrochloride) 100 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
amoxicillin (som amoxicillintrihydrat) 250 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
amoxicillin (som amoxicillintrihydrat) 250 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
amoxicillin (som amoxicillintrihydrat) 500 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
amoxicillin (som amoxicillintrihydrat) 500 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely fluvastatin (as fluvastatin sodium) 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely fluvastatin (as fluvastatin sodium) 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Indinavir (as indinavir sulfate) 100 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Indinavir (as indinavir sulfate) 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
cefadroxil (som cefadroxilmonohydrat) 500 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
cefadroxil (som cefadroxilmonohydrat) 500 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely anagrelide (as anagrelide hydrochloride) 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely anagrelide (as anagrelide hydrochloride) 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
cefaklor (som cefaklormonohydrat) 250 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
cefaklor (som cefaklormonohydrat) 250 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely fluvastatin (as fluvastatin sodium) 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely fluvastatin (as fluvastatin sodium) 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Ketotifen (as ketotifen fumarate) 1 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Ketotifen (as ketotifen fumarate) 1 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
cefaklor (som cefaklormonohydrat) 500 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
cefaklor (som cefaklormonohydrat) 500 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Minocycline (as minocycline hydrochloride) 100 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Minocycline (as minocycline hydrochloride) 100 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely tropisetron (as tropisetron hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely tropisetron (as tropisetron hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely minocycline (as minocycline hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely topotecan (as topotecan hydrochloride) 250 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely topotecan (as topotecan hydrochloride) 250 microgram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin sodium) 500 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Flucloxacillin (as flucloxacillin sodium) 500 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely loxapine (as loxapine succinate) 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely loxapine (as loxapine succinate) 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
ampicillin (som ampicillintrihydrat) 250 milligram och floxacillin (som natriumflukloxacillin) 250 milligram, oral kapsel |
Has unit of presentation |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
ampicillin (som ampicillintrihydrat) 250 milligram och floxacillin (som natriumflukloxacillin) 250 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
2 |
ampicillin (som ampicillintrihydrat) 250 milligram och floxacillin (som natriumflukloxacillin) 250 milligram, oral kapsel |
Has presentation strength denominator unit (attribute) |
False |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Levothyroxine sodium anhydrous 25 microgram oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Levothyroxine sodium anhydrous 25 microgram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely loxapine (as loxapine succinate) 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely loxapine (as loxapine succinate) 25 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely disopyramide (as disopyramide phosphate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely loxapine (as loxapine succinate) 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely loxapine (as loxapine succinate) 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Levothyroxine sodium anhydrous 150 microgram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Levothyroxine sodium anhydrous 150 microgram oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely disopyramide (as disopyramide phosphate) 150 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Levothyroxine sodium anhydrous 50 microgram oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Levothyroxine sodium anhydrous 50 microgram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Flucloxacillin (as flucloxacillin sodium) 250 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Flucloxacillin (as flucloxacillin sodium) 250 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Imatinib (as imatinib mesilate) 400 mg oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Imatinib (as imatinib mesilate) 400 mg oral capsule |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |
Product containing precisely levothyroxine sodium anhydrous 75 microgram/1 each conventional release oral capsule (clinical drug) |
Has unit of presentation |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
|
Levothyroxine sodium anhydrous 100 microgram oral capsule |
Has presentation strength denominator unit (attribute) |
True |
Capsule (unit of presentation) |
Inferred relationship |
Some |
1 |